236 related articles for article (PubMed ID: 37598343)
21. Construction and validation of nomograms to reduce completion thyroidectomy by predicting lymph node metastasis in low-risk papillary thyroid carcinoma.
Wang R; Tang Z; Wu Z; Xiao Y; Li J; Zhu J; Zhang X; Ming J
Eur J Surg Oncol; 2023 Aug; 49(8):1395-1404. PubMed ID: 37061404
[TBL] [Abstract][Full Text] [Related]
22. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
23. Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis.
Li F; Zhou FJ; Zhu TW; Qiu HL; Zhang XT; Ruan BW; Huang DY
Adv Clin Exp Med; 2023 Jul; 32(7):753-761. PubMed ID: 36603142
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis.
Zhao J; Zhang Y; Zheng X
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):635-638. PubMed ID: 35210104
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
[TBL] [Abstract][Full Text] [Related]
26. Integrating US-guided FNAB, BRAF
Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
[TBL] [Abstract][Full Text] [Related]
27. Related factor analysis for predicting large-volume central cervical lymph node metastasis in papillary thyroid carcinoma.
Tan L; Ji J; Sharen G; Liu Y; Lv K
Front Endocrinol (Lausanne); 2022; 13():935559. PubMed ID: 36046785
[TBL] [Abstract][Full Text] [Related]
28. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
29. Unilateral papillary thyroid carcinoma treated with contralateral central lymph node dissection: A nomogram to aid in decision-making.
Chen W; Li Z; Zhu J; Lei J; Wei T
Medicine (Baltimore); 2020 Sep; 99(38):e22200. PubMed ID: 32957351
[TBL] [Abstract][Full Text] [Related]
30. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
[TBL] [Abstract][Full Text] [Related]
31. Dual-Energy Computed Tomography Parameters Combined With Inflammatory Indicators Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer.
Wei L; Wu Y; Bo J; Fu B; Sun M; Zhang Y; Xiong B; Dong J
Cancer Control; 2024; 31():10732748241262177. PubMed ID: 38881040
[TBL] [Abstract][Full Text] [Related]
32. Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.
Min Y; Huang Y; Wei M; Wei X; Chen H; Wang X; Chen J; Xiang K; Feng Y; Yin G
Front Endocrinol (Lausanne); 2021; 12():713475. PubMed ID: 34367075
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound-based radiomics nomogram combined with clinical features for the prediction of central lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis.
Jin P; Chen J; Dong Y; Zhang C; Chen Y; Zhang C; Qiu F; Zhang C; Huang P
Front Endocrinol (Lausanne); 2022; 13():993564. PubMed ID: 36060946
[TBL] [Abstract][Full Text] [Related]
34. Cervical lymph node metastasis prediction of postoperative papillary thyroid carcinoma before
Yu F; Wu W; Zhang L; Li S; Yao X; Wang J; Ni Y; Meng Q; Yang R; Wang F; Shi L
Front Endocrinol (Lausanne); 2023; 14():1122517. PubMed ID: 36875475
[TBL] [Abstract][Full Text] [Related]
35. A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto's thyroiditis to predict central lymph node metastasis.
Zhao W; He L; Zhu J; Su A
Clin Endocrinol (Oxf); 2021 Feb; 94(2):310-321. PubMed ID: 32984984
[TBL] [Abstract][Full Text] [Related]
36. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
37. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
Heo DB; Won HR; Tae K; Kang YE; Jeon E; Ji YB; Chang JW; Choi JY; Yu HW; Ku EJ; Lee EK; Kim M; Choe JH; Koo BS;
Surgery; 2024 Apr; 175(4):1049-1054. PubMed ID: 38281855
[TBL] [Abstract][Full Text] [Related]
38. A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.
Yang Z; Heng Y; Zhao Q; Cao Z; Tao L; Qiu W; Cai W
Front Endocrinol (Lausanne); 2021; 12():743900. PubMed ID: 34659126
[TBL] [Abstract][Full Text] [Related]
39. Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer.
Zhou Y; Su GY; Hu H; Tao XW; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
Acad Radiol; 2022 Mar; 29 Suppl 3():S222-S231. PubMed ID: 34366279
[TBL] [Abstract][Full Text] [Related]
40. Nomograms based on sonographic and clinicopathological characteristics to predict lateral lymph node metastasis in classic papillary thyroid carcinoma.
Feng JW; Wu WX; Qi GF; Hong LZ; Hu J; Liu SY; Jiang Y; Ye J
J Endocrinol Invest; 2022 Nov; 45(11):2043-2057. PubMed ID: 35809195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
